CN119630790A - 新型lrp1结合肽 - Google Patents

新型lrp1结合肽 Download PDF

Info

Publication number
CN119630790A
CN119630790A CN202380056691.4A CN202380056691A CN119630790A CN 119630790 A CN119630790 A CN 119630790A CN 202380056691 A CN202380056691 A CN 202380056691A CN 119630790 A CN119630790 A CN 119630790A
Authority
CN
China
Prior art keywords
group
peptide
amino acid
acid
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380056691.4A
Other languages
English (en)
Chinese (zh)
Inventor
坂元孝太郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ichimaru Pharcos Co Ltd
Original Assignee
Ichimaru Pharcos Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ichimaru Pharcos Co Ltd filed Critical Ichimaru Pharcos Co Ltd
Publication of CN119630790A publication Critical patent/CN119630790A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN202380056691.4A 2022-08-05 2023-06-29 新型lrp1结合肽 Pending CN119630790A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022-125238 2022-08-05
JP2022125238 2022-08-05
PCT/JP2023/024137 WO2024029242A1 (ja) 2022-08-05 2023-06-29 新規ｌｒｐ１結合ペプチド

Publications (1)

Publication Number Publication Date
CN119630790A true CN119630790A (zh) 2025-03-14

Family

ID=89848802

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380056691.4A Pending CN119630790A (zh) 2022-08-05 2023-06-29 新型lrp1结合肽

Country Status (4)

Country Link
EP (1) EP4541891A1 (https=)
JP (2) JP7665261B2 (https=)
CN (1) CN119630790A (https=)
WO (1) WO2024029242A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7713129B1 (ja) * 2023-12-28 2025-07-24 一丸ファルコス株式会社 組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015526434A (ja) * 2012-08-14 2015-09-10 アンジオケム インコーポレーテッド ペプチド−デンドリマーコンジュゲート及びその使用
JP7110800B2 (ja) 2018-07-31 2022-08-02 株式会社三洋物産 遊技機
US11644426B2 (en) * 2020-08-11 2023-05-09 Applied Materials Israel Ltd. Methods and systems for generating calibration data for wafer analysis
CA3128035A1 (en) * 2020-08-13 2022-02-13 Bioasis Technologies, Inc. Combination therapies for delivery across the blood brain barrier

Also Published As

Publication number Publication date
EP4541891A1 (en) 2025-04-23
JP7665261B2 (ja) 2025-04-21
JPWO2024029242A1 (https=) 2024-02-08
WO2024029242A1 (ja) 2024-02-08
JP2025102922A (ja) 2025-07-08

Similar Documents

Publication Publication Date Title
JP7819087B2 (ja) インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用
CN101389648B (zh) 肽胃泌酸调节素衍生物
JP7796636B2 (ja) ヒトトランスフェリンレセプター結合ペプチド
US12528846B2 (en) BH4 stabilized peptides and uses thereof
EP3630806B1 (en) Long-acting gip peptide analogues
MX2013004350A (es) Analogos de peptido insulinotropico dependientes de glucosa.
CN111447941A (zh) 用于细胞内递送装订肽的多肽缀合物
CN114630836A (zh) 补体抑制素类似物及其医学用途
WO2015142701A1 (en) Compstatin analogs with improved potency and pharmacokinetic properties
EP3970801A1 (en) Ras inhibitory peptide
JP2025120320A (ja) Ｖｉｐｒ２アンタゴニストペプチド
JP2025102922A (ja) 新規ｌｒｐ１結合ペプチド
JP2004002331A (ja) 肝臓癌の治療
WO2022265109A1 (en) Ghr-binding pending peptide and composition comprising same
EP4667483A1 (en) Human transferrin receptor-binding peptide
CN117136192A (zh) 缀合的铁调素模拟物
HK40083520A (en) Human transferrin receptor binding peptide
Zamudio Vázquez Synthesis, Biological Evaluation and Insights into the Mode of Action of Quinoxaline Containing Peptides
HK1133385A (en) Methods and compositions related to improving properties of pharmacological agents targeting nervous system

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination